CTSS and cancer: Among the cancer drugs that activate lysosomal cell death are microtubule-destabilizing and -stabilizing drugs (e.g. vinca alkaloids and taxanes), which inhibit lysosomal trafficking and induce an expansion of the lysosomal compartment followed by lysosomal rupture and cathepsin-dependent cell death [7], [8].